Ruhlmann F

No ORCID on file · 2 papers in corpus
2021
Efficacy, safety, and immunogenicity of a biosimilar recombinant human follicle-stimulating hormone (Folitime®) vs. Gonal-f® in women undergoing ovarian stimulation for IVF: A randomized, multicenter, evaluator-blinded, non-inferiority study.
JBRA assisted reproduction ·doi:10.5935/1518-0557.20210023

ObjectiveWe compared the efficacy, safety, and immunogenicity of a biosimilar recombinant human follicle-stimulating hormone (Folitime®) with Gonal-f® in women undergoing ovarian stimulation for in-vitro fertilization.MethodsThis randomized …

2017
Optimizing the number of embryos to transfer on day 5: two should be the limit.
JBRA assisted reproduction ·doi:10.5935/1518-0557.20170003

ObjectiveTo define the appropriate number of embryos to be transferred at day 5.MethodsRetrospective analysis of 784 consecutive fresh day-5 embryo transfers performed between 2007 and 2015, divided in three groups: Group A (N = 219): recei…